A Precision Workflow for Clinical Bioprinting – Presented by Derek Mathers, Advanced Solutions Life Sciences, at the 3D Medical Conference, which takes place on January 30-31, 2019, at MECC Maastricht, The Netherlands.
Current bioprocess manufacturing focuses on biologic replacement therapies and monoclonal antibodies. We are at the beginning of a new wave of therapies wherein the cell is the therapy.
We have seen large investments and regulatory approvals for T-cell therapies but if we only address immunotherapy, we will miss the most significant opportunity of today’s medical society: the opportunity to manufacture patient-specific replacement parts.
We present here the vision of a workflow to address the need to generate replacement structures, tissues, and eventually organs that are living, bespoke, autologous, and regulated. Continue reading “A Precision Workflow for Clinical Bioprinting – Presented by Derek Mathers, Advanced Solutions Life Sciences”